Cargando…

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: Ki-67 is an established marker of cell proliferation, and the Ki-67 index correlates with the clinical course of several cancer types, including bladder cancer (BC). However, the clinicopathological and prognostic significance of Ki-67 in bladder cancer remains unclear. Therefore, we per...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yuejun, Ma, Zhiming, Chen, Zhaohui, Li, Mingguo, Wu, Zhiping, Hong, Mei, Wang, Hanzhang, Svatek, Robert, Rodriguez, Ronald, Wang, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943634/
https://www.ncbi.nlm.nih.gov/pubmed/27410033
http://dx.doi.org/10.1371/journal.pone.0158891
_version_ 1782442627240558592
author Tian, Yuejun
Ma, Zhiming
Chen, Zhaohui
Li, Mingguo
Wu, Zhiping
Hong, Mei
Wang, Hanzhang
Svatek, Robert
Rodriguez, Ronald
Wang, Zhiping
author_facet Tian, Yuejun
Ma, Zhiming
Chen, Zhaohui
Li, Mingguo
Wu, Zhiping
Hong, Mei
Wang, Hanzhang
Svatek, Robert
Rodriguez, Ronald
Wang, Zhiping
author_sort Tian, Yuejun
collection PubMed
description BACKGROUND: Ki-67 is an established marker of cell proliferation, and the Ki-67 index correlates with the clinical course of several cancer types, including bladder cancer (BC). However, the clinicopathological and prognostic significance of Ki-67 in bladder cancer remains unclear. Therefore, we performed a systematic review and meta-analysis to clarify this relationship. METHODS: A comprehensive literature search for relevant studies published up to February 1, 2016, was performed using PubMed, Cochrane Library, Embase and ISI Web of Knowledge. The effects of Ki-67 expression on survival outcome in patients with BC and BC subtypes were evaluated. Furthermore, the relationship between Ki-67 expression and the clinicopathological features of BC were assessed. RESULTS: Thirty-one studies with 5147 bladder cancer patients were selected for evaluation. Ki-67 expression was significantly associated with shorter recurrence-free (HR 1.69, 95% CI: 1.33–2.14), progression-free (HR 1.89, 95% CI: 1.43–2.51), overall (HR 2.03, 95% CI: 1.31–3.16), and cancer-specific (HR 1.69, 95% CI: 1.47–1.95) survival. Moreover, whereas high expression was more common in high tumor stage, recurrence status, tumor size, there was no correlation between high Ki-67 expression and age, gender, smoking habits, and tumor number. Importantly, analysis of the different subgroups of BC suggested that significant correlations between high Ki-67 expression and survival outcome (recurrence-free/progression-free/overall/cancer-specific survival) are present only in European-American patients. CONCLUSION: The present results indicate that over-expression of Ki-67 is distinctly correlated with poor patient survival. Ki-67 may serve as a valuable biomarker for prognosis in BC patients, particularly in non-Asian BC patients. The results suggest no significant association between Ki-67 expression and BC prognosis in Asian patients. Further efforts are needed to fully clarify this relationship.
format Online
Article
Text
id pubmed-4943634
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49436342016-08-01 Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis Tian, Yuejun Ma, Zhiming Chen, Zhaohui Li, Mingguo Wu, Zhiping Hong, Mei Wang, Hanzhang Svatek, Robert Rodriguez, Ronald Wang, Zhiping PLoS One Research Article BACKGROUND: Ki-67 is an established marker of cell proliferation, and the Ki-67 index correlates with the clinical course of several cancer types, including bladder cancer (BC). However, the clinicopathological and prognostic significance of Ki-67 in bladder cancer remains unclear. Therefore, we performed a systematic review and meta-analysis to clarify this relationship. METHODS: A comprehensive literature search for relevant studies published up to February 1, 2016, was performed using PubMed, Cochrane Library, Embase and ISI Web of Knowledge. The effects of Ki-67 expression on survival outcome in patients with BC and BC subtypes were evaluated. Furthermore, the relationship between Ki-67 expression and the clinicopathological features of BC were assessed. RESULTS: Thirty-one studies with 5147 bladder cancer patients were selected for evaluation. Ki-67 expression was significantly associated with shorter recurrence-free (HR 1.69, 95% CI: 1.33–2.14), progression-free (HR 1.89, 95% CI: 1.43–2.51), overall (HR 2.03, 95% CI: 1.31–3.16), and cancer-specific (HR 1.69, 95% CI: 1.47–1.95) survival. Moreover, whereas high expression was more common in high tumor stage, recurrence status, tumor size, there was no correlation between high Ki-67 expression and age, gender, smoking habits, and tumor number. Importantly, analysis of the different subgroups of BC suggested that significant correlations between high Ki-67 expression and survival outcome (recurrence-free/progression-free/overall/cancer-specific survival) are present only in European-American patients. CONCLUSION: The present results indicate that over-expression of Ki-67 is distinctly correlated with poor patient survival. Ki-67 may serve as a valuable biomarker for prognosis in BC patients, particularly in non-Asian BC patients. The results suggest no significant association between Ki-67 expression and BC prognosis in Asian patients. Further efforts are needed to fully clarify this relationship. Public Library of Science 2016-07-13 /pmc/articles/PMC4943634/ /pubmed/27410033 http://dx.doi.org/10.1371/journal.pone.0158891 Text en © 2016 Tian et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Tian, Yuejun
Ma, Zhiming
Chen, Zhaohui
Li, Mingguo
Wu, Zhiping
Hong, Mei
Wang, Hanzhang
Svatek, Robert
Rodriguez, Ronald
Wang, Zhiping
Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis
title Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis
title_full Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis
title_fullStr Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis
title_full_unstemmed Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis
title_short Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis
title_sort clinicopathological and prognostic value of ki-67 expression in bladder cancer: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943634/
https://www.ncbi.nlm.nih.gov/pubmed/27410033
http://dx.doi.org/10.1371/journal.pone.0158891
work_keys_str_mv AT tianyuejun clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis
AT mazhiming clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis
AT chenzhaohui clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis
AT limingguo clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis
AT wuzhiping clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis
AT hongmei clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis
AT wanghanzhang clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis
AT svatekrobert clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis
AT rodriguezronald clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis
AT wangzhiping clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis